Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Delgado

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Pharmacotherapy|September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelinesRavina Kullar, Steven N Leonard, Susan L Davis, et al.
Infectious Diseases and Therapy|March 28, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureusKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Issues in Law & Medicine|September 6, 2014
A second opinion: response to 100 professorsDaniel Wechter, Donna Harrison, Robert Adams, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Pharmacotherapy|September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelinesRavina Kullar, Steven N Leonard, Susan L Davis, et al.
Infectious Diseases and Therapy|March 28, 2019
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureusKimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
Issues in Law & Medicine|September 6, 2014
A second opinion: response to 100 professorsDaniel Wechter, Donna Harrison, Robert Adams, et al.
Pageof 2